Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study.
about
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies.Improvement of psychological status after infliximab treatment in patients with newly diagnosed Crohn's disease.Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database
P2860
Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Efficacy and Safety of Inflixi ...... Nationwide, Multicenter Study.
@en
Efficacy and Safety of Inflixi ...... Nationwide, Multicenter Study.
@nl
type
label
Efficacy and Safety of Inflixi ...... Nationwide, Multicenter Study.
@en
Efficacy and Safety of Inflixi ...... Nationwide, Multicenter Study.
@nl
prefLabel
Efficacy and Safety of Inflixi ...... Nationwide, Multicenter Study.
@en
Efficacy and Safety of Inflixi ...... Nationwide, Multicenter Study.
@nl
P2093
P2860
P1476
Efficacy and Safety of Inflixi ...... Nationwide, Multicenter Study.
@en
P2093
Byong Duk Ye
Byung Ik Jang
Chang Hwan Choi
Chang Kyun Lee
Dong Il Park
Dong Soo Han
Eun Soo Kim
Hyo Jong Kim
Hyun Joo Song
P2860
P304
P356
10.3349/YMJ.2016.57.6.1376
P50
P577
2016-11-01T00:00:00Z